Responses
Late-breaking abstracts
Combination immunotherapies
819 Targeting vasoactive intestinal peptide receptor signaling: a novel approach to enhance anti-tumor response in pancreatic ductal adenocarcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
